UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 638

Sortiert nach

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma

PloS one, 2019-02, Vol.14 (2), p.e0211927-e0211927

2019

Link zum Volltext

Verfügbarkeit prüfen

The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment

PloS one, 2014-07, Vol.9 (7), p.e101819-e101819

2014

Link zum Volltext

Verfügbarkeit prüfen

A new Norwegian Injury Registration System as a starting point to assess the burden of injuries in Norway

European journal of public health, 2023-10, Vol.33 (Supplement_2)

Lund, Johan

2023

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of studies measuring health-related quality of life of general injury populations

BMC public health, 2010-12, Vol.10 (1), p.783-783, Article 783

2010

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of fatal occupational injury registration in a high-income country: A comparison of two-source capture-recapture estimates with the number of cases identified in four register systems in Norway, 2000–2003

Global Epidemiology, 2022-12, Vol.4, p.100072-100072, Article 100072

2022

Link zum Volltext

Verfügbarkeit prüfen

Minimal residual disease status is the prognostic determinant following high‐dose treatment for patients with multiple myeloma

Cancer medicine (Malden, MA), 2023-11, Vol.12 (22), p.20736-20744

2023

Link zum Volltext

Verfügbarkeit prüfen

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma

PloS one, 2015-09, Vol.10 (9), p.e0138248-e0138248

2015

Link zum Volltext

Verfügbarkeit prüfen

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study

Cancer reports, 2022-11, Vol.5 (11), p.e1614-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Mangelfull overvåking av skadedødsfall i norsk landbasert arbeidsliv

Norsk epidemiologi, 2016, Vol.26 (1)

2016

Link zum Volltext

Verfügbarkeit prüfen

964 Risk factors for hip fractures due to falls in the elderly during one year 2014/15 in kiev

Injury prevention, 2016-09, Vol.22 (Suppl 2), p.A343-A343

2016

Link zum Volltext

Verfügbarkeit prüfen

Acetylation of Steroidogenic Factor 1 Protein Regulates Its Transcriptional Activity and Recruits the Coactivator GCN5

The Journal of biological chemistry, 2001-10, Vol.276 (40), p.37659-37664

2001

Link zum Volltext

Verfügbarkeit prüfen

Incidence of injuries in Norway: linking primary and secondary care data

Scandinavian journal of public health, 2020-05, Vol.48 (3), p.323-330

2020

Link zum Volltext

Verfügbarkeit prüfen

Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program

BLOOD, 2022-11, Vol.140 (Supplement 1), p.12605-12606

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of Sp1 in cAMP-dependent Transcriptional Regulation of the Bovine CYP11A Gene

The Journal of biological chemistry, 1999-07, Vol.274 (27), p.19422-19428

1999

Link zum Volltext

Verfügbarkeit prüfen

Museet vid korsvägen

Lund, Johan

2016

Link zum Volltext

Verfügbarkeit prüfen

Conditioning with melphalan 200 mg/m 2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care

European journal of haematology, 2022-12, Vol.109 (6), p.749-754

2022

Link zum Volltext

Verfügbarkeit prüfen

Explaining reduction of pedestrian-motor vehicle crashes in Arkhangelsk, Russia, in 2005-2010

International journal of circumpolar health, 2012-01, Vol.71 (1), p.19107-19107

2012

Link zum Volltext

Verfügbarkeit prüfen

A Two-receptor Pathway for Catabolism of Clara Cell Secretory Protein in the Kidney

The Journal of biological chemistry, 2001-04, Vol.276 (16), p.13295-13301

2001

Link zum Volltext

Verfügbarkeit prüfen

475 Fatal occupational injuries in Norway: surveillance data are biassed and underestimated risk

Injury prevention, 2016-09, Vol.22 (Suppl 2), p.A172-A173

2016

Link zum Volltext

Verfügbarkeit prüfen

Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care

European journal of haematology, 2022-12, Vol.109 (6), p.749-754

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to Caravita di Toritto and Rago

European journal of haematology, 2023-02, Vol.110 (2), p.224-225

2023

Link zum Volltext

Verfügbarkeit prüfen

Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy

Cancer Immunology, Immunotherapy, 2023-05, Vol.72 (5), p.1153-1167

2023

Link zum Volltext

Verfügbarkeit prüfen

Dynamic follow‐up of smoldering multiple myeloma identifies a subset of patients at high risk of progression

American journal of hematology, 2021-03, Vol.96 (3), p.E63-E65

2021

Link zum Volltext

Verfügbarkeit prüfen

Injury severity and increased socioeconomic differences: A population-based cohort study

Injury, 2022-06, Vol.53 (6), p.1904-1910

2022

Link zum Volltext

Verfügbarkeit prüfen

Antibody response to COVID‐19 mRNA vaccine (Comirnaty) in myeloma patients treated with high‐dose melphalan and/or immunotherapy

American journal of hematology, 2021-11, Vol.96 (11), p.E443-E446

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 638

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(556)
Mit Volltextzugriff
(590)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(606)
Japanisch
(43)
Norwegisch
(37)
Bokmål, Norwegian; Norwegian Bokmål
(12)
Dänisch
(2)
Russisch
(2)
Schwedisch
(2)
Französisch
(1)
Deutsch
(1)

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma

The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment

A new Norwegian Injury Registration System as a starting point to assess the burden of injuries in Norway

A systematic review of studies measuring health-related quality of life of general injury populations

Accuracy of fatal occupational injury registration in a high-income country: A comparison of two-source capture-recapture estimates with the number of cases identified in four register systems in Norway, 2000–2003

Minimal residual disease status is the prognostic determinant following high‐dose treatment for patients with multiple myeloma

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study

Mangelfull overvåking av skadedødsfall i norsk landbasert arbeidsliv

964 Risk factors for hip fractures due to falls in the elderly during one year 2014/15 in kiev

Acetylation of Steroidogenic Factor 1 Protein Regulates Its Transcriptional Activity and Recruits the Coactivator GCN5

Incidence of injuries in Norway: linking primary and secondary care data

Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program

Role of Sp1 in cAMP-dependent Transcriptional Regulation of the Bovine CYP11A Gene

Museet vid korsvägen

Conditioning with melphalan 200 mg/m 2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care

Explaining reduction of pedestrian-motor vehicle crashes in Arkhangelsk, Russia, in 2005-2010

A Two-receptor Pathway for Catabolism of Clara Cell Secretory Protein in the Kidney

475 Fatal occupational injuries in Norway: surveillance data are biassed and underestimated risk

Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care

Response to Caravita di Toritto and Rago

Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy

Dynamic follow‐up of smoldering multiple myeloma identifies a subset of patients at high risk of progression

Injury severity and increased socioeconomic differences: A population-based cohort study

Antibody response to COVID‐19 mRNA vaccine (Comirnaty) in myeloma patients treated with high‐dose melphalan and/or immunotherapy

Suchergebnisse filtern